Trial of varenicline (Champix) for the treatment of spinocerebellar degeneration
spinocerebellar degeneration (SCD)
[High-dose Group] Oral administration of varenicline
1-7 days 0.5 mg/day 8-14 days 1.0mg/day 15-21 days 1.5mg/day 22-56 days 2.0 mg/day 57-63 days 1.0 mg/day 64-70 days 0.5 mg/day 71-84 days Wash-out period 85-154 days 0.5 mg/day [Low-dose Group] Oral administration of varenicline
1-70 days 0.5 mg/day 71-84 days Wash-out period 85-91 days 0.5 mg/day 92-98 days 1.0mg/day 99-105 days 1.5mg/day 106-140 days 2.0 mg/day 141-147 days 1.0 mg/day 148-154 days 0.5 mg/day [High-dose Group] Oral administration of varenicline
1-7 days 0.5 mg/day 8-14 days 1.0mg/day 15-21 days ...